PAR paradigm biopharmaceuticals limited..

The Ghosh Study - PART 1, page-3

  1. 4,913 Posts.
    lightbulb Created with Sketch. 7651
    Hi Aviza,

    Thanks for the feedback. Yes it is taking its own sweet time isn't it. RRV Peer review also took at least a year and a bit longer than we thought. There can be a fair bit of to'ing and fro'ing. I think we should have it by second half this year. At the end of the day these reports and observations by others like Ghosh and Kumagai are kinda like Peer reviews but yes, we still want an official one covering specifically our 008 data. n was small but the data was mighty, offering clues across a number of endpoints. It will be validation for sure.




 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
40.0¢
Change
-0.030(6.98%)
Mkt cap ! $158.9M
Open High Low Value Volume
41.5¢ 42.5¢ 40.0¢ $171.8K 418.0K

Buyers (Bids)

No. Vol. Price($)
7 118996 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
41.0¢ 10760 1
View Market Depth
Last trade - 16.10pm 28/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.